Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab
Clinical trial NCT03249714 · COMPLETED
Trial details
- NCT number
- NCT03249714
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2019-12-26
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.